CTSD and metabolic dysfunction-associated steatotic liver disease: Relevantly, while we demonstrate a positive correlation between hepatic CTSD expression and hepatic inflammation, Fukuo et al. showed reduced levels of hepatic CTSD in NAFLD patients14.